CVS Health (NYSE: CVS) reported Q1 2026 revenue of $100.4 billion in an SEC 8-K filing, representing a 6.2% increase versus the prior-year period.
📊 Stock Price at Article Time (May 7, 2026, 7:00 AM KST)
$86.86 ▲ +7.65%
~₩125,773 (1,448 KRW/USD)
Q1 Earnings at a Glance
All business segments posted revenue growth. Notably, profitability in the health insurance division—anchored by subsidiary Aetna—improved substantially. Adjusted operating income (excluding one-time items) climbed 12.5% versus the prior year.
- Revenue: $100.4 billion, +6.2% YoY
- GAAP EPS: $2.30, up 63% from $1.41 prior year
- Adjusted EPS (ex one-time items): $2.57, up 14.2% from $2.25 prior year
- Operating income: $4.68 billion, +38.7% YoY
- Adjusted operating income: $5.15 billion, +12.5% YoY
- Operating cash flow: $4.2 billion
Full-Year 2026 Guidance
CVS Health raised its full-year 2026 outlook. GAAP EPS guidance was increased from $5.94–$6.14 to $6.24–$6.44. Adjusted EPS guidance was raised from $7.00–$7.20 to $7.30–$7.50. Operating cash flow guidance was lifted to a minimum of $9.5 billion from $9.0 billion. Full-year revenue guidance was set at a minimum of $405 billion. However, the company noted it remains cautious on the second half given persistent cost inflation and lingering macroeconomic uncertainty. CEO David Joyner stated, "We will continue to build growth momentum through disciplined strategy execution."
Market Reaction
The day after earnings (May 7, 7:00 AM KST), CVS stock climbed 7.65% to $86.86. Investor's Business Daily attributed the rally to improved Aetna profitability and the company's exit from the ACA individual insurance market. Morningstar cited margin improvement in the health insurance segment as the key driver. International media outlets also highlighted management commentary suggesting the company can achieve its Medicare Advantage margin targets by 2028.
Segment Performance
- Health Insurance (incl. Aetna): Revenue $35.97 billion, +3.3% YoY. Adjusted operating income $3.04 billion, +52.6% YoY
- Medical Benefits Ratio (MBR): 84.6%, improving 270 basis points from 87.3% prior year
- Health insurance members: 26 million, down ~600k from year-end (due to ACA market exit)
- Healthcare services and pharmacy segment: All divisions posted revenue gains (partial details provided in SEC filing)
This article was auto-generated from SEC 8-K filings and third-party news reports to deliver key data immediately following earnings release. Investors are encouraged to review official company filings before making trading decisions. Stock price reflects the article publication timestamp and may differ from current levels.
